MH3D

Ann Arbor, MI —April 20 th , 2026— MH3D, Inc., a leader in next-generation quantitative SPECT imaging technology, today announced that Minerva Imaging, a globally recognized contract research organization (CRO), has purchased an Alpha-SPECT TM Mini unit, marking the first adoption of MH3D’s technology in Europe. This commercial milestone represents growing demand for high-precision, quantitative imaging solutions in pre-clinical theranostics research. MH3D’s Alpha-SPECT TM Mini is...

Ann Arbor, MI — April 15th, 2026 — MH3D Inc., a developer of next-generation quantitative SPECT imaging systems, today announced the sale of a Alpha-SPECT™ Mini unit to Perceptive Discovery, a leading contract research organization (CRO). The system will be used to support the launch of α-Sight™ , a new pre-clinical imaging service focused on alpha-emitting radiopharmaceuticals. This transaction marks a key commercial milestone for MH3D and reflects increasing demand for imaging technologies...

BALTIMORE, MD – November, 2025 – MH3D is proud to officially announce the first commercial installation of its flagship preclinical SPECT/CT imaging system, the Alpha-SPECT™ Mini. The state-of-the-art system has been installed at the prestigious Johns Hopkins University School of Medicine. The Alpha-SPECT™ Mini represents a significant leap forward in preclinical imaging technology. It is the only preclinical SPECT imaging scanner on the market utilizing CZT (Cadmium Zinc Telluride)...